Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 21505207)

1.

Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes.

Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K, Yatoh S, Takahashi A, Yahagi N, Yagyu H, Sone H, Shimano H.

J Diabetes Res. 2015;2015:507245. doi: 10.1155/2015/507245. Epub 2015 Mar 26.

2.

Trends in the Risk for Cardiovascular Disease among Adults with Diabetes in Oman.

Al-Lawati J, Morsi M, Al-Riyami A, Mabry R, El-Sayed M, El-Aty MA, Al-Lawati H.

Sultan Qaboos Univ Med J. 2015 Feb;15(1):e39-45. Epub 2015 Jan 21.

3.

Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study.

Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh F.

PLoS One. 2014 Dec 2;9(12):e112639. doi: 10.1371/journal.pone.0112639. eCollection 2014.

5.

Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.

Xu J, Wang P, Wang T, Wang M, Chen S, Yu P, Yu D.

BMC Cardiovasc Disord. 2014 Sep 10;14:114. doi: 10.1186/1471-2261-14-114.

6.

Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.

Carson AP, Tanner RM, Yun H, Glasser SP, Woolley JM, Thacker EL, Levitan EB, Farkouh ME, Rosenson RS, Brown TM, Howard G, Safford MM, Muntner P.

Ann Epidemiol. 2014 Aug;24(8):581-7. doi: 10.1016/j.annepidem.2014.05.007. Epub 2014 May 22.

PMID:
24970491
7.

Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus.

Kaushal S, Singh H, Thangaraju P, Singh J.

N Am J Med Sci. 2014 Mar;6(3):107-13. doi: 10.4103/1947-2714.128471. Review.

8.

Association between Sleep Disruption and Levels of Lipids in Caucasians with Type 2 Diabetes.

Wan Mahmood WA, Draman Yusoff MS, Behan LA, Di Perna A, Kyaw Tun T, McDermott J, Sreenan S.

Int J Endocrinol. 2013;2013:341506. doi: 10.1155/2013/341506. Epub 2013 Aug 29.

9.

The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization.

Nichols GA, Rosales AG, Perrin NA, Fortmann SP.

Diabetes Care. 2014 Jan;37(1):167-72. doi: 10.2337/dc13-1300. Epub 2013 Aug 29.

10.

Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.

Wong ND, Patao C, Wong K, Malik S, Franklin SS, Iloeje U.

Diab Vasc Dis Res. 2013 Nov;10(6):505-13. doi: 10.1177/1479164113496828. Epub 2013 Aug 22.

11.
12.

Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in China.

Foody J, Huo Y, Ji L, Zhao D, Boyd D, Meng HJ, Shiff S, Hu D.

Clin Med Insights Cardiol. 2013 Apr 4;7:59-86. doi: 10.4137/CMC.S10225. Print 2013.

13.

Smoking behavior among US adults with diabetes or impaired fasting glucose.

Clair C, Meigs JB, Rigotti NA.

Am J Med. 2013 Jun;126(6):541.e15-8. doi: 10.1016/j.amjmed.2012.11.029. Epub 2013 Apr 15.

14.

Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies.

Olafsdottir E, Aspelund T, Sigurdsson G, Benediktsson R, Thorsson B, Harris TB, Launer LJ, Eiriksdottir G, Gudnason V.

BMC Public Health. 2013 Jan 15;13:36. doi: 10.1186/1471-2458-13-36.

15.

Standards of medical care in diabetes--2013.

American Diabetes Association.

Diabetes Care. 2013 Jan;36 Suppl 1:S11-66. doi: 10.2337/dc13-S011. No abstract available.

16.

Differences in statin usage and target-goal achievement between departments at the same hospital.

Chen Z, Wang X, Ding Z, Fan P, Ma G.

PLoS One. 2012;7(12):e50466. doi: 10.1371/journal.pone.0050466. Epub 2012 Dec 10.

17.

Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.

Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, Kashiwagi A, Uzu T, Maegawa H.

Diabetes Care. 2013 May;36(5):1248-53. doi: 10.2337/dc12-1298. Epub 2012 Dec 5.

18.

The imperative to prevent diabetes.

Ratner RE.

Diabetes Care. 2012 Dec;35(12):2417-8. doi: 10.2337/dc12-1997. No abstract available.

19.

Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.

Davis TM, Hunt K, McAullay D, Chubb SA, Sillars BA, Bruce DG, Davis WA.

Diabetes Care. 2012 Oct;35(10):2005-11. Epub 2012 Jul 18.

20.

Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey.

Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L.

Diabetes Care. 2012 Jun;35(6):1252-7. doi: 10.2337/dc11-1162.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk